Anticipated shortage
Generic transition period — Pfizer brand discontinuing following patent expiry. Generic uptake not yet sufficient to cover gap.
Expected resolution: 31 October 2025
pregabalin
Lyrica
300 mg · capsule · Neuropathic Pain
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $54.60 |
PBS Information
- Item code
- ANAx09
- Drug name
- pregabalin
- Brand name
- Lyrica
- Manufacturer
- Pfizer
- Formulation
- capsule
- Strength
- 300 mg
- Max quantity
- 56 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Neuropathic Pain
TGA Reference: TGA-MSI-2025-004 · Sponsor: Pfizer Australia Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.